Skip to content

BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment After a Long-term Use (Pilot).

BreEStim for Post-Stroke Motor Recovery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04752319
Enrollment
4
Registered
2021-02-12
Start date
2025-09-01
Completion date
2028-03-31
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor Recovery

Keywords

Finger flexor spasticity, Motor Recovery, BreEStim

Brief summary

The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with moderate impairment after a long-term use.

Interventions

DEVICEBreEStim

BreEStim will be applied for 10 to 20 minutes per session for multiple sessions

DEVICEEStim

EStim will be applied for 10 to 20 minutes per session for multiple sessions

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* has post stroke ≥ 6 months , medically stable; * Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); * MAS score ≥ 1, i.e., detectable finger flexor hypertonia;

Exclusion criteria

include: * Patients with visual deficit/neglect; hearing or cognitive impairment; * Patients with history of pulmonary disease (Asthma, chronic obstruction pulmonary disease, COPD); * Patients that are currently adjusting tone alternating medications (e.g., baclofen), or * Patients received botulinum toxin injection to the arm/fingers \<4 months, or phenol injections \< 2 years; * Patients with a pacemaker; * Women who are pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)Baseline, after 10 intervention sessions, about 3 weeksMAS will be performed to check changes of finger flexor spasticity after one session of treatment. The Modified Ashworth scale (MAS) scoring is categorical and ranges from 0 to 4, as follows: 0: No increase in muscle tone 1. Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of motion (ROM) 2. More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved 3. Considerable increase in muscle tone, passive movement difficult 4. Affected part(s) rigid in flexion or extension

Secondary

MeasureTime frameDescription
Change in finger extensors and hand function measured by Fugl Myer Assessment (FMA) ScaleBaseline, after 10 intervention sessions, about 3 weeksFMA will be assessed to test function changes of finger extensors and hand function after one session of treatment. The upper limb motor function domain of the FMA scale will be used, and the score range for this domain is 0 to 66, with a higher score indicating better function.

Countries

United States

Contacts

Primary ContactSheng Li, MD, PhD
sheng.li@uth.tmc.edu(713) 797-7125
Backup ContactShengai Li, MS
shengai.li@uth.tmc.edu713-797-7561

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026